Orpea SA (ORPEF)
USD 14.22
(0.0%)
USD 14.22
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.19 Billion EUR | 81.26% |
| 2022 | -710.95 Million USD | -271.55% |
| 2021 | 414.43 Million USD | -20.57% |
| 2020 | 521.74 Million USD | -7.57% |
| 2019 | 564.45 Million USD | 16.07% |
| 2018 | 486.29 Million USD | 7.56% |
| 2017 | 452.1 Million USD | 29.07% |
| 2016 | 350.26 Million USD | 8.2% |
| 2015 | 323.72 Million USD | -9.47% |
| 2014 | 357.59 Million USD | 15.46% |
| 2013 | 309.72 Million USD | 23.65% |
| 2012 | 250.48 Million USD | 22.02% |
| 2011 | 205.28 Million USD | 18.89% |
| 2010 | 172.67 Million USD | 4.39% |
| 2009 | 165.41 Million USD | 25.85% |
| 2008 | 131.43 Million USD | 24.03% |
| 2007 | 105.97 Million USD | 45.1% |
| 2006 | 73.03 Million USD | 56.42% |
| 2005 | 46.69 Million USD | 7.52% |
| 2004 | 43.42 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -13.92 Million USD | 88.02% |
| 2023 Q4 | -116.19 Million USD | -591.09% |
| 2023 Q1 | -6.49 Million EUR | 98.67% |
| 2023 Q3 | -1.48 Million EUR | 90.35% |
| 2023 FY | -120.68 Million EUR | 97.18% |
| 2023 Q2 | -16.81 Million USD | 96.79% |
| 2022 FY | -4.27 Billion EUR | -1304.58% |
| 2022 Q4 | -523.07 Million USD | -184.32% |
| 2022 Q3 | -65.44 Million EUR | 62.72% |
| 2022 Q1 | 40.88 Million EUR | -72.59% |
| 2022 Q2 | -183.97 Million USD | -208.54% |
| 2021 Q4 | 169.5 Million USD | -33.67% |
| 2021 FY | 354.66 Million EUR | -24.05% |
| 2021 Q2 | 255.54 Million USD | -8.67% |
| 2021 Q3 | 82.53 Million EUR | -61.7% |
| 2021 Q1 | 115.32 Million EUR | -49.57% |
| 2020 Q2 | 222.08 Million USD | -23.87% |
| 2020 FY | 466.99 Million EUR | -7.3% |
| 2020 Q1 | 98.38 Million EUR | -62.14% |
| 2020 Q4 | 279.81 Million USD | 25.99% |
| 2020 Q3 | 113.07 Million EUR | -42.82% |
| 2019 Q3 | 129.85 Million EUR | -46.56% |
| 2019 Q1 | 122.03 Million EUR | 8.08% |
| 2019 FY | 503.78 Million EUR | 17.79% |
| 2019 Q2 | 276.7 Million USD | 4.21% |
| 2019 Q4 | 291.7 Million USD | 5.42% |
| 2018 Q4 | 265.53 Million USD | 17.77% |
| 2018 Q3 | 112.91 Million EUR | 11.87% |
| 2018 Q2 | 225.47 Million USD | -4.29% |
| 2018 Q1 | 100.93 Million EUR | -2.15% |
| 2018 FY | 427.69 Million EUR | 8.45% |
| 2017 Q1 | 94.03 Million EUR | 1.92% |
| 2017 FY | 394.35 Million EUR | 13.3% |
| 2017 Q3 | 103.14 Million EUR | 9.69% |
| 2017 Q4 | 235.57 Million USD | 14.55% |
| 2017 Q2 | 205.66 Million USD | 14.9% |
| 2016 Q4 | 178.99 Million USD | 10.23% |
| 2016 FY | 348.07 Million EUR | 14.68% |
| 2016 Q2 | 162.38 Million EUR | 0.0% |
| 2016 Q3 | 92.25 Million EUR | 12.82% |
| 2016 Q1 | 81.77 Million EUR | -0.65% |
| 2015 Q3 | 82.31 Million EUR | 18.52% |
| 2015 Q4 | 82.31 Million EUR | 0.0% |
| 2015 FY | 303.51 Million EUR | 11.9% |
| 2015 Q1 | 69.44 Million EUR | -9.5% |
| 2015 Q2 | 69.44 Million EUR | 0.0% |
| 2014 Q1 | 58.88 Million EUR | 1.36% |
| 2014 FY | 271.24 Million EUR | 19.34% |
| 2014 Q4 | 76.73 Million EUR | 0.0% |
| 2014 Q3 | 76.73 Million EUR | 30.31% |
| 2014 Q2 | 58.88 Million EUR | 0.0% |
| 2013 Q2 | 55.54 Million EUR | 0.0% |
| 2013 Q4 | 58.09 Million EUR | 0.0% |
| 2013 FY | 227.28 Million EUR | 16.91% |
| 2013 Q1 | 55.54 Million EUR | 0.0% |
| 2013 Q3 | 58.09 Million EUR | 4.6% |
| 2012 FY | 194.4 Million EUR | 2.34% |
| 2011 FY | 189.96 Million EUR | 25.74% |
| 2010 FY | 151.08 Million EUR | 12.29% |
| 2009 FY | 134.54 Million EUR | 25.88% |
| 2008 FY | 106.88 Million EUR | 30.4% |
| 2007 FY | 81.97 Million EUR | 35.38% |
| 2006 FY | 60.54 Million EUR | -19.06% |
| 2005 FY | 74.8 Million EUR | 99.45% |
| 2004 FY | 37.5 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -25.84 Million USD | 20215.393% |
| Arem Pacific Corporation | -23.6 Thousand USD | 22024590.488% |
| Assisted 4 Living, Inc. | -121.58 Thousand USD | 4275439.074% |
| BioCorRx Inc. | -3.78 Million USD | 137330.199% |
| Bionik Laboratories Corp. | -4.82 Million USD | 107829.699% |
| Banyan Corp. | -1.59 Million USD | 326222.009% |
| Clearday, Inc. | -11.85 Million USD | 43956.404% |
| Dental Patient Care America, Inc. | -31.55 Thousand USD | 16471881.221% |
| Quantum Medical Transport, Inc. | 222.84 USD | -2332615229.384% |
| Empower Clinics Inc. | -4.95 Million USD | 105018.684% |
| First Choice Healthcare Solutions, Inc. | -2.41 Million USD | 215746.171% |
| Selectis Health, Inc. | -8.96 Million USD | 58110.68% |
| Ethema Health Corporation | -541.92 Thousand USD | 959282.167% |
| HealthLynked Corp. | -3.83 Million USD | 135756.032% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 195926.758% |
| JRSIS Health Care Corporation | -188.59 Thousand USD | 2756226.788% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 67.1 Million USD | -7645.608% |
| MedSmart Group Inc. | -84.51 Thousand USD | 6150851.39% |
| North America Frac Sand, Inc. | -702.5 Thousand USD | 740028.826% |
| Nova Leap Health Corp. | 460.15 Thousand USD | -1129526.732% |
| Nexteligent Holdings, Inc. | -201.72 Thousand USD | 2576862.539% |
| PAO Group, Inc. | -45.42 Thousand USD | 11444397.666% |
| Primemd Inc. | 4.15 Million USD | -124889.3% |
| Raffles Medical Group Ltd | 87.71 Million USD | -5825.958% |
| Ryman Healthcare Limited | -26.98 Million USD | 19360.876% |
| Stem Cell Authority, Ltd. | -4230.00 USD | 122884260.757% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.25 Million USD | 231041.341% |
| Mycotopia Therapies, Inc. | -616.72 Thousand USD | 842940.558% |
| U.S. NeuroSurgical Holdings, Inc. | -765 Thousand USD | 679577.124% |
| Veltex Corporation | -1.08 Million USD | 480273.668% |
| World Financial Holding Group | -28.43 Thousand USD | 18283603.342% |
| Xcelerate Inc. | -2.61 Million USD | 199053.866% |